Reply to Palle Osther's Words of Wisdom re: Inhibition of Sodium-Glucose Cotransporter 2 Suppresses Renal Stone Formation. Eur Urol. 2023;84:243-44

Affiliations

¹ Department of Urology, Yotsuya Medical Cube, Tokyo, Japan; Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: g-anan@mcube.jp.
² Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
³ Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.

Comment

Go Anan et al. Eur Urol. 2023 Dec.

. 2023 Dec;84(6):e147-e148.

doi: 10.1016/j.eururo.2023.06.019. Epub 2023 Jul 7.

¹ Department of Urology, Yotsuya Medical Cube, Tokyo, Japan; Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: g-anan@mcube.jp.
² Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan; Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
³ Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.

No abstract available

Comment on

Re: Inhibition of Sodium-Glucose Cotransporter 2 Suppresses Renal Stone Formation.
Osther P. Osther P. Eur Urol. 2023 Aug;84(2):243-244. doi: 10.1016/j.eururo.2023.03.009. Epub 2023 Mar 22. Eur Urol. 2023. PMID: 36964038 No abstract available.